Ulcus cruris venosum (UCV) is the most severe form of chronic venous insufficiency and the quality of life of those affected is usually significantly impaired. In the updated s2k guideline published in 2024, the focus was on the prevention of UCV recurrences in addition to the quality of examination and treatment procedures. It is a practice-oriented guideline that combines the different approaches and levels of knowledge of the respective professional groups and offers a practicable treatment concept for UCV.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Suicide
Dealing with trauma after suicide loss: What do bereaved people experience as effective?
- COPD exacerbations
Fast therapy initiation is not much better than expected
- Galenic systems
Advantages of topical pharmacotherapy – Update 2025
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Psychedelics and related drug classes
Ritual, party or new therapy? Psychedelics and more: clinically illuminated
- Acute sinusitis: real-world study on first-line therapy
Focusing on a rational therapeutic approach beyond antibiotics
- DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline
Stroke prevention for atrial fibrillation 2025
- Prurigo nodularis and AD